Cargando…
Potency, Efficacy and Durability of DNA/DNA, DNA/Protein and Protein/Protein Based Vaccination Using gp63 Against Leishmania donovani in BALB/c Mice
BACKGROUND: Visceral leishmaniasis (VL) caused by an intracellular protozoan parasite Leishmania, is fatal in the absence of treatment. At present there are no effective vaccines against any form of leishmaniasis. Here, we evaluate the potency, efficacy and durability of DNA/DNA, DNA-prime/Protein-b...
Autores principales: | Mazumder, Saumyabrata, Maji, Mithun, Das, Amrita, Ali, Nahid |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3032732/ https://www.ncbi.nlm.nih.gov/pubmed/21311597 http://dx.doi.org/10.1371/journal.pone.0014644 |
Ejemplares similares
-
Potentiating Effects of MPL on DSPC Bearing Cationic Liposomes Promote Recombinant GP63 Vaccine Efficacy: High Immunogenicity and Protection
por: Mazumder, Saumyabrata, et al.
Publicado: (2011) -
Vaccine Development Against Leishmania donovani
por: Das, Amrita, et al.
Publicado: (2012) -
Insights from the analysis of a predicted model of gp63 in Leishmania donovani
por: Razzazan, Ali, et al.
Publicado: (2008) -
Leishmania mexicana Gp63 cDNA Using Gene Gun Induced Higher Immunity to L. mexicana Infection Compared to Soluble Leishmania Antigen in BALB/C
por: Rezvan, H, et al.
Publicado: (2011) -
Absence of Metalloprotease GP63 Alters the Protein Content of Leishmania Exosomes
por: Hassani, Kasra, et al.
Publicado: (2014)